Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 743-749

  Kakurai, Maki ^a,c   Fujita, Nobuya ^b   Murata, Satoru ^a   Furukawa, Yusuke ^c   Demitsu, Toshio ^d   Nakagawa, Hidemi ^a  

^a Department of Medicine ^*  (Japan)

^b Department of Medicine   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokines; Dermatoses; Neuropeptides; Skin

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INFLAMMATORY DISEASE; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DISEASE;

EID: 0035012323     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01306.x     Document Type: Article

References (53)

1. Al'abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ: Neuropeptides and general neuronal marker in psoriasis - an immunohistochemical study. Clin Exp Dermatol 20:384-389, 1995
2. Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR: Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 124:547-549, 1991
3. Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL: The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv Neuroimmunol 6:5-27, 1996
4. Bjorklund H, Dalsgaard CJ, Jonsson CE, Hermansson A: Sensory and autonomic innervation of non-hairy and hairy human skin. An immunohistochemical study. Cell Tissue Res 243:51-57, 1986
5. Bloom SR, Polak JM: Regulatory peptides and the skin. Clin Exp Dermatol 8:3-18, 1983
6. Calvo JR, Guerrero JM, Molinero P, Blasco R, Goberna R: Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: specific binding and cyclic AMP production. Gen Pharmacol 17:185-189, 1986
7. Couvineau A, Rouyer-Fessard C, Darmoul D, Maoret J-J, Carrero I, Ogier-Denis E, Laburthe M: Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun 200:769-776, 1994
8. Danek A, O'Dorisio MS, O'Dorisio TM, George JM: Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol 131:1173-1177, 1983
9. Ganea D: Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv Neuroimmunol 6:61-74, 1996
10. Ganea D, Sun L: Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN γ from stimulated murine T lymphocytes. J Neuroimmunol 47:147-158, 1993
11. Giannetti A, Fantini F, Cimitan A, Pincelli C: Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Stockh Suppl 176:90-92, 1992
12. Goetzl EJ, Pankhaniya RR, Gaufo GO, Mu Y, Xia M, Sreedharan SP: Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann NY Acad Sci 840:540-550, 1998
13. 17-VIP, induce proliferation of keratinocytes. FEBS Lett 475:78-83, 2000
14. Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Gorberna R: Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 21:151-160, 1981
15. Haegerstrand A, Jonzon B, Dalsgaard CJ, Nilsson J: Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 86:5993-5996, 1989
16. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97:389-394, 1991
17. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S: Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819, 1992
18. Johnston JA, Taub DD, Lloyd AR, Conlon K, Oppenheim JJ, Kevlin DJ: Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol 153:1762-1768, 1994
19. Kim TY, Park HJ, Kim CW: Eosinophil carionic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases. J Dermatol Sci 15:89-94, 1997
20. ++ concentration. J Invest Dermatol 89:167-171, 1987
21. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Sience 243:1464-1466, 1989
22. Leung DYM: Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 104:S99-S108, 1999
23. Locci T, Hautmann G, Panconesi E: Neuropeptides in skin. J Am Acad Dermatol 33:482-496, 1995
24. Lowman MA, Benyon RC, Church MK: Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 95:121-130, 1988
25. Lundeberg L, Nordlind K: Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study. Arch Dermatol Res 291:201-206, 1999
26. Lundin A, Fredens K, Michaëlsson G, Venge P: The eosinophil granulocyte in psoriasis. Br J Dermatol 122:181-193, 1990
27. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8, 1993
28. Neuner P, Urbanski A, Trautinger F, et al: Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97:27-33, 1991
29. Nilsson SFE, Maepea O: Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat. Acta Physiol Scand 129:17-26, 1987
30. Ostlere LS, Cowen T, Rustin MH: Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 20:462-467, 1995
31. Ottaway CA, Greenberg GR: Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol 132:417-423, 1984
32. Ottaway CA, Bernaerts C, Chan B, Greenberg GR: Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 61:664-671, 1983
33. 17]-VIP. Am J Physiol 250:G553-G557, 1986
34. Park SK, Olson TA, Ercal N, Summers M, O'Dorisio MS: Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets. Blood 87:4629-4635, 1996
35. Park YM, Kim CW: The effects of substance P and vasoactive intestinal peptide interleukin-6 synthesis in cultured human kerationcytes. J Dermatol Sci 2:17-23, 1999
36. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A: Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 122:745-750, 1990
37. Pincelli C, Fantini F, Romualdi P, Lesa G, Giannetti A: Skin levels of vasoactive intestinal polypeptide in atopic dermatitis. Arch Dermatol Res 283:230-232, 1991
38. Pincelli C, Fantini F, Romualdi P, Sevignani C, Lesa G, Benassi L, Giannetti A: Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 98:421-427, 1992
39. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC: Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81-96, 1998
40. Shenker BJ, Kushner ME, Tsai C-C: Inhibition of fibroblast proliferation by acionobacillus actinomycetemcomitans. Infection Immunity 38:986-992, 1982
41. Sreedharan SP, Patel DR, Huang J-X, Goetzl EJ: Cloning and functional expression of a human neuroendcrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 193:546-553, 1993
42. Sreedharan SP, Huang J-X, Cheung MC, Goetzl EJ: Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci USA 92:2939-2943, 1995
43. Sung KJ, Chang SE, Paik EM, Lee MW, Choi JH: Vasoactive intestinal peptide stimulates the proliferation of HaCaT cell via TGF-α. Neuropeptides 33:435-446, 1999
44. Svoboda M, Tastenoy M, Van Rampelbergh J, Goossens J-F, De Neef P, Waelbroeck M, Robberecht P: Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun 205:1617-1624, 1994
45. Takahashi K, Nakanishi S, Imamura S: Direct effects of cutaneous neuropeptides on adenylase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 101:646-651, 1993
46. Tang H, Sun L, Xin Z, Ganea D: Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann N Y Acad Sci 805:768-778, 1996
47. Usdin TB, Bonner TI, Mezey É: Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135:2662-2680, 1994
48. Wei Y, Mojsov S: Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J Neuroendocrinol 8:811-817, 1996
49. Weller EM, Poot M, Hoehn H: Induction of replicative senescence by 5-azacytidine: fundamental cell kinetic differences between human diploid fibroblasts and NIH-3T3 cells. Cell Prolif 26:45-54, 1993
50. Wollina U, Huschenbeck J, Knöll B, Sternberg B, Hipler U-C: Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix. Regul Pept 70:29-36, 1997
51. Wong GG, Clark SC: Multiple actions of interleukin 6 within cytokine network. Immunol Today 9:137-139, 1988
52. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237, 1987
53. Zhang L, Redington AE, Holgate ST: RANTES. a novel mediator of allergic inflammation? Clin Exp Allergy 24:899-904, 1994